Idorsia presented the following two posters at EPA25:

• Time to therapeutic effect with daridorexant: Weekly analysis of patient-reported outcomes from a Phase 3 randomized, placebo-controlled study in patients with insomnia disorder - presented by Talitha Bakker
• Effect of daridorexant on wakefulness throughout the night: Post-hoc analysis of a randomized, double-blind, active reference (zolpiderm) study in patients with insomnia disorder - presented by Orestis Briasoulis

Unravelling the Complexities of Chronic Insomnia with Comorbid Depression or Anxiety

Idorsia hosted a symposium on 7 April, 2025 from 13:15 to 14:45 at EPA. 

• Download the flyer

Eduard Vieta

University of Barcelona,
Barcelona, Spain

Hugh Selsick

Royal London Hospital,
London, United Kingdom

Pierre-Alexis Geoffroy

Paris Cité University and Beaujon & Bichat Hospitals

Paris, France

Laura Palagini

University of Pisa,

Pisa, Italy